LataMed AI is trading at $0.08, up 16.26%, with the move appearing primarily sector-driven as healthcare stocks outperform.
- Healthcare stocks rose 1.27% amid renewed biotechnology optimism and acquisition interest, while broader U.S. markets declined on September 24, 2026.
- No new company-specific announcement dated September 24 was identified; the latest verifiable release was the September 9 Venezuelan healthcare cooperation agreement.
- The rebound follows a sharp decline from $0.30 on September 18 to $0.12 on September 22.